This transcript is for your personal, non-commercial usage only. Distribution and usage of this worldly are governed by our Subscriber Agreement and by copyright law. For non-personal usage oregon to bid aggregate copies, delight contact Dow Jones Reprints astatine 1-800-843-0008 oregon sojourn www.djreprints.com.
https://www.wsj.com/articles/the-fda-wants-to-interfere-in-the-practice-of-medicine-physicians-patients-medical-devices-treatment-11673562165
A little-noticed proviso of the omnibus spending measure could springiness the bureau powerfulness to prohibition off-label usage of approved therapies.
By Joel Zinberg
Jan. 12, 2023 6:49 p.m. ET
Secreted wrong the 2023 omnibus appropriations bill—4,155 pages, spending $1.7 trillion—is a 19-line conception that could alteration the mode medicine is practiced.
Physicians routinely prescribe drugs and employment aesculapian devices that are approved and labeled by the Food and Drug Administration for a peculiar use. Yet sometimes physicians discern different beneficial uses for these technologies, which they prescribe for their patients without circumstantial authoritative sanction. The caller authorities amends the Food, Drug and Cosmetic Act, oregon FDCA, to springiness the FDA the authorization to prohibition immoderate of these off-label uses of different approved products. This unwarranted intrusion into the physician-patient narration threatens to undermine aesculapian innovation and diligent care.